| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 46 |
| 1 | ASPIRIN 325 MG | 45 |
| 2 | ASPIRIN 81 MG | 45 |
| 3 | FUROSEMIDE | 42 |
| 4 | LEVOTHYROXINE SODIUM | 40 |
| 5 | METFORMIN | 38 |
| 6 | OMEPRAZOLE MAGNESIUM | 35 |
| 7 | METFORMIN ER 500 MG | 33 |
| 8 | METFORMIN ER 750 MG | 33 |
| 9 | ACETAMINOPHEN | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 1 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| 2 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 3 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 4 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 5 | CLINDAMYCIN PHOSPHATE | 7 | 0.0013 |
| 6 | TRANYLCYPROMINE SULFATE | 1 | 0.0012 |
| 7 | LANADELUMAB-FLYO | 4 | 0.0012 |
| 8 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 5 | 0.0012 |
| 9 | CEFTAROLINE FOSAMIL | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 103 |
| 1 | Corticosteroid [EPC] | 75 |
| 2 | Loop Diuretic [EPC] | 54 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 52 |
| 4 | Benzodiazepine [EPC] | 52 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 47 |
| 6 | Vitamin C [EPC] | 39 |
| 7 | Proton Pump Inhibitor [EPC] | 38 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 35 |
| 9 | Thiazide Diuretic [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 4 | 0.0017 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 3 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 4 | Provitamin D2 Compound [EPC] | 28 | 0.0009 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 6 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |